Oestrogen plus progestin increased risk of stroke and probable dementia in postmenopausal womenEffect of estrogen plus progestin on stroke in postmenopausal women: the Womens Health Initiative: a randomized trial.Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.

  • Wassertheil-Smoller, S
  • Hendrix, SL
  • Limacher, M
  • et al,
  • Shumaker, SA
  • Legault, C
  • Rapp, SR
  • et al,
  • Rapp, SR
  • Espeland, MA
  • Shumaker, SA
  • et al,

Wassertheil-Smoller S, Hendrix SL, Limacher M, et al.Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial.JAMA 2003;289:2673–84.Wassertheil-SmollerSHendrixSLLimacherMet alEffect of estrogen plus progestin on stroke in postmenopausal women: the Womens Health Initiative: a randomized trial.JAMA20032892673-84Shumaker SA, Legault C, Rapp SR, et al.Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial.JAMA 2003;289:2651–62.ShumakerSALegaultCRappSRet alEstrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.JAMA20032892651-62Rapp SR, Espeland MA, Shumaker SA, et al.Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial.JAMA 2003;289:2663–72.RappSREspelandMAShumakerSAet alEffect of estrogen plus progestin on global cognitive function in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.JAMA20032892663-72

Sources of funding: Wyeth Pharmaceuticals and National Heart, Lung, and Blood Institute.

Abstract and commentary also appear in ACP Journal Club.

For correspondence: Dr S Wassertheil-Smoller, Albert Einstein College of Medicine, Bronx, NY, USA.[email protected] Dr SA Shumaker, Wake Forest University Health Sciences, Winston-Salem, NC, USA.[email protected] Dr SR Rapp, Wake Forest University School of Medicine, Winston-Salem, NC, USA.[email protected]

Sources of funding: Wyeth Pharmaceuticals and National Heart, Lung, and Blood Institute.

Abstract and commentary also appear in ACP Journal Club.

Evidence Based Medicine 8(6):p 170-171, November-December 2003.
Copyright © British Medical Journal 2003.